RecruitingNCT04464655
A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Enrollment
2,130 participants
Start Date
Dec 12, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to identify and assess new CMR techniques that can improve current CMR protocols.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Healthy Volunteers
- Age: > 18y, Informed consent No known current or pre-existing significant medical conditions that would affect the cardiovascular or respiratory system
- Age: >18 y, Informed consent, Clinically indicated CMR exam
Exclusion Criteria4
- General MRI contraindications: MR- incompatible devices such as pacemakers, defibrillators, or implanted material or foreign bodies. Consumption of caffeinated drinks or foods (including cocoa and chocolate) during the 12 hours prior to the exam.Regular nicotine consumption during the last 6 months
- Patients
- General MRI contraindications: MR- incompatible devices such as pacemakers, defibrillators, or implanted material or foreign bodies Vasoactive medication (e.g. nitro) during the 12 hours prior to the exam. Consumption of caffeinated drinks or foods (including cocoa and chocolate) during the 12 hours prior to the exam.
- Regular nicotine consumption during the last 6 months
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04464655
Related Trials
Prenatal Maternal Mental Health and Neurodevelopment in Congenital Heart Disease
NCT067116665 locations
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
NCT052135981 location
Late-lumen Changes After Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stents in De Novo Coronary Lesions
NCT069547148 locations
Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study
NCT068211911 location
A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
NCT0736128915 locations